title: Amelioration of sodium barbital-induced nephropathy and regenerative tubular hyperplasia after a single injection of streptozotocin does not abolish the renal tumor promoting effect of barbital sodium in male F344/NC4 rats.
abstract: The renal tumor promoting activity of barbital sodium (BBNa) and the role of renal tubular cell hyperplasia in tumor promotion following initiation with streptozotocin (STZ) was investigated. Six week old male F344/NCr rats were given STZ as a single i.p. injection of 50 mg/kg body wt and beginning 2 weeks later were fed diets containing 0 or 4000 p.p.m. of BBNa until they were killed at 33, 52 or 72 experimental weeks for histological evaluation and determination of levels of renal DNA synthesis by bromodeoxyuridine (Brdu) immunohistochemistry. A promoting effect on renal carcinogenesis was found by 72 weeks, but not at 33 or 52 weeks, confirming that prolonged administration of BBNa is necessary to promote renal tubular cell neoplasms. The promoting effect was evident as a higher incidence of large renal tubular tumors after 52 weeks, rather than an increase in number of dysplastic tubules, putative preneoplastic lesions. These findings suggest that the targets for the promoting activity of BBNa may be dysplastic lesions which may progress to tumors. Detailed examination by the step section technique through the entire kidneys revealed that STZ or BBNa administration induced a high incidence of putative preneoplastic renal tubular lesions (dysplasias) which seemed to be derived from the P1 or P2 segment of the nephron, also a site of high Brdu labeling index (LI) associated with BBNa toxicity. STZ administration was also associated with attenuation of BBNa-induced nephropathy and with diabetes from pancreatic islet degeneration and atrophy. The reduction in severity of nephropathy was correlated with a reduction in the LI of the renal cortical and medullary tubules, but not with the renal tumor incidence. These results indicate that decreased DNA synthesis in target cells does not eliminate tumor promoting activity in renal tubular epithelium. In addition, BBNa alone induced papillomas of the transitional epithelium of the renal pelvis and renal tubular cell adenomas.
authors: Tumor Pathology and Pathogenesis Section, National Cancer Institute, Frederick, MD 21702-1201.
authors: N
authors: N
authors: Konishi
authors: B A
authors: BA
authors: Diwan
authors: J M
authors: JM
authors: Ward
mesh_terms: D000236:Adenoma / Q000209:etiology; D000818:Animals; D001462:Barbital / Q000494:pharmacology*; D001835:Body Weight / Q000187:drug effects; D004247:DNA / Q000096:biosynthesis; D006965:Hyperplasia / Q000139:chemically induced / Q000150:complications; D007668:Kidney / Q000033:anatomy & histology / Q000378:metabolism / Q000473:pathology; D007680:Kidney Neoplasms / Q000209:etiology; D008099:Liver / Q000033:anatomy & histology; D008297:Male; D009393:Nephritis / Q000139:chemically induced / Q000150:complications; D009929:Organ Size / Q000187:drug effects; D010212:Papilloma / Q000209:etiology; D051381:Rats; D011916:Rats, Inbred F344; D013311:Streptozocin / Q000494:pharmacology
chemical_list: D013311:Streptozocin; D001462:Barbital; D004247:DNA